Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Cervical Cancer Brachytherapy Amid the Pandemic: A Single Institutional Case Series



Siavashpour Z1 ; Jafari F2, 4 ; Aghili M2, 4 ; Jafari A1 ; Jaberi R2, 3
Authors

Source: Onkologia i Radioterapia Published:2021

Abstract

Dose escalation to target volume during High Dose Rate brachytherapy was effectively employed to treat locally advanced cervical cancer patients who experienced prolongation of Overall Treatment Time (OTT) due to the COVID-19 pandemic. It was tried to achieve acceptable oncological outcomes while respecting the dose constraints of Organs at Risk (OARs). Key Clinical Message: It was a severe challenge to obey the optimum treatment schedule of LACC cases during the coronavirus crisis. Increased risk of recurrence and mortality due to increased overall treatment time in cervical cancer patients proposes prioritizing. © 2021, Medical Project Poland. All rights reserved.
Related Docs
View other Related Docs
1. Optimum Organ Volume Ranges for Organs at Risk Dose in Cervical Cancer Intracavitary Brachytherapy, Journal of Contemporary Brachytherapy (2016)
2. Dose to Pelvic Lymph Nodes During Brachytherapy of Locally Advanced Cervical Cancer With 60Co Hdr Source, Brachytherapy (2022)
3. Brachytherapy During the Coronavirus Disease 2019 – Lessons From Iran, Brachytherapy (2020)
Experts (# of related papers)
View all Related Experts
Setareh Akhavan (5)
Mahdi Aghili (5)
Other Related Docs
4. Short Course Brachytherapy in Locally Advanced Cervical Cancer; Safety and Response Rate, Asian Pacific Journal of Cancer Prevention (2024)
5. Adjuvant High-Dose-Rate Brachytherapy in the Management of Oral Cavity Cancers: 5 Years of Experience in Iran, Journal of Contemporary Brachytherapy (2017)
6. Radiation Therapy for Breast Cancer During the Covid-19 Pandemic in Low Resource Countries: Consensus Statement From the Iranian Society of Radiation Oncology, International Journal of Cancer Management (2022)
7. Concomitant Boost Chemoradiotherapy in Locally Advanced Head and Neck Cancer: Treatment Tolerance and Acute Side Effects, Journal of Cancer Research and Therapeutics (2015)
8. Comparison of Therapeutic Effects of Chemo-Radiotherapy With Neoadjuvant Chemotherapy Before Radical Surgery in Patients With Bulky Cervical Carcinoma (Stage Ib3 & Iia2), BMC Cancer (2021)
9. Evaluation of Survival Rate and Associated Factors in Patients With Cervical Cancer: A Retrospective Cohort Study, Journal of Research in Health Sciences (2022)
10. Chemo-Radiotherapy After Neoadjuvant Chemotherapy and Radical Hysterectomy in Women With Stage Ib-Iib Cervical Cancer: Do We Need to Change the Therapeutic Approach? a Cohort Study, Surgery in Practice and Science (2025)
11. Covid19 Prevention & Care; a Cancer Specific Guideline, Archives of Iranian Medicine (2020)
12. An Expert Opinion Regarding the Management of Lower Gastrointestinal Cancers During Covid-19 Outbreak in Iran: A Brief Report, Acta Medica Iranica (2021)
13. Management Policies of Breast Cancer Surgery, Chemotherapy and Radiotherapy During Covid-19 Outbreak in Iran, World Cancer Research Journal (2020)
14. The Outcome of Locally Advanced Cervical Cancer in Patients Treated With Neoadjuvant Chemotherapy Followed by Radical Hysterectomy and Primary Surgery, Iranian Journal of Medical Sciences (2021)
15. Hypofractionated Versus Standard Chemoradiotherapy in the Definitive Treatment of Uterine Cervix Cancer: Interim Results of a Randomized Controlled Clinical Trial, Journal of Cancer Research and Clinical Oncology (2025)
16. A Comparison of Organs at Risk Doses in Gyn Intracavitary Brachytherapy for Different Tandem Lengths and Bladder Volumes, Journal of Applied Clinical Medical Physics (2016)
17. What Is the Best Treatment Option for Head and Neck Cancers in Covid-19 Pandemic? a Rapid Review, American Journal of Otolaryngology - Head and Neck Medicine and Surgery (2020)
18. Concurrent Chemo- Radiobrachytherapy With Cisplatin and Medium Dose Rate Intra- Cavitary Brachytherapy for Locally Advanced Uterine Cervical Cancer, Asian Pacific Journal of Cancer Prevention (2018)
19. Gec-Estro Recommendations for Head & Neck Cancer Brachytherapy (Interventional Radiotherapy): 2Nd Update With Focus on Hdr and Pdr, Radiotherapy and Oncology (2024)
20. Clinical Efficacy Analysis of Preoperative Neoadjuvant Chemotherapy With High-Dose Dense Paclitaxel Plus Cisplatin in Stages Ib2, Iia2, Iib Cervical Cancer in Iran, European Journal of Gynaecological Oncology (2016)